Thus, our data demonstrated that LCL-PLP administered alone exerted stimulatory action on the levels of the subunit α of the transcription factor HIF-1 (Figure 6A,B) that is constitutively expressed in aggressive melanoma cells [44,45]. The gene discussed is HIF1A; the disease is melanoma.